MRUS
Merus BV
NASDAQ: MRUS · HEALTHCARE · BIOTECHNOLOGY
$90.00
+0.00% today
Updated 2025-12-30
Market cap
$6.83B
P/E ratio
—
P/S ratio
120.59x
EPS (TTM)
$-5.28
Dividend yield
—
52W range
$33 – $97
Volume
1.3M
Merus BV (MRUS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $558000.00 | $1.30M | $1.91M | $2.51M | $21.91M | $33.50M | $27.76M | $24.51M | $43.15M | $38.84M | $39.81M | $34.88M |
| Revenue growth (YoY) | — | +133.5% | +46.2% | +31.8% | +773.1% | +52.9% | -17.1% | -11.7% | +76.0% | -10.0% | +2.5% | -12.4% |
| Cost of revenue | $6.05M | $11.57M | $16.18M | $18.42M | $34.13M | $47.81M | $49.64M | $57.33M | $86.27M | $9.95M | $10.50M | $21.92M |
| Gross profit | $-5.50M | $-10.26M | $-14.28M | $-15.91M | $-12.21M | $-14.31M | $-21.88M | $-32.82M | $-43.12M | $28.88M | $29.31M | $12.96M |
| Gross margin | -984.9% | -787.6% | -749.4% | -634.0% | -55.7% | -42.7% | -78.8% | -133.9% | -99.9% | 74.4% | 73.6% | 37.2% |
| R&D | $6.05M | $12.39M | $16.18M | $18.42M | $34.13M | $52.17M | $53.65M | $62.25M | $94.44M | $148.23M | $132.75M | $229.90M |
| SG&A | $3.94M | $550000.00 | $768000.00 | $4.26M | $13.70M | $25.62M | $28.80M | $29.29M | $35.93M | $48.75M | $54.20M | $79.96M |
| Operating income | $-9.91M | $-17.42M | $-23.11M | $-27.88M | $-35.30M | $-39.93M | $-52.29M | $-62.11M | $-79.05M | $-149.46M | $-141.80M | $-262.63M |
| Operating margin | -1775.3% | -1336.9% | -1213.2% | -1110.8% | -161.1% | -119.2% | -188.4% | -253.4% | -183.2% | -384.8% | -356.2% | -753.0% |
| EBITDA | $-9.64M | $-11.76M | $-18.50M | $-26.16M | $-33.95M | $-39.27M | $-49.67M | $-60.93M | $-77.75M | $-148.26M | $-139.50M | $-260.24M |
| EBITDA margin | -1728.0% | -902.8% | -971.1% | -1042.1% | -154.9% | -117.2% | -179.0% | -248.6% | -180.2% | -381.7% | -350.4% | -746.1% |
| EBIT | $-9.91M | $-12.02M | $-18.69M | $-26.39M | $-34.26M | $-39.93M | $-50.69M | $-62.11M | $-79.05M | $-149.46M | $-141.80M | $-262.63M |
| Interest expense | $75947.00 | $47424.00 | $213193.00 | $20.66M | $227943.00 | $4575.00 | $6.45M | $18.56M | $129000.00 | $2.72M | $14.51M | $30.79M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-9.91M | $-17.41M | $-23.26M | $-47.44M | $-64.77M | $-24.71M | $-49.17M | $-70.00M | $-58.70M | $-122.52M | $-140.34M | $-207.85M |
| Net income growth (YoY) | — | -75.7% | -33.6% | -104.0% | -36.5% | +61.8% | -99.0% | -42.4% | +16.1% | -108.7% | -14.5% | -48.1% |
| Profit margin | -1775.6% | -1336.1% | -1220.8% | -1889.9% | -295.6% | -73.8% | -177.1% | -285.6% | -136.1% | -315.5% | -352.6% | -595.9% |